Efficacy and Safety of TACE Combined with Regorafenib Plus PD-1 Inhibitor in the Treatment of Hepatocellular Carcinoma After Sorafenib Resistance
Article in Journal of Hepatocellular Carcinoma (February 2023)
The most recent citing publications are shown below. View all 23 publications that cite this research output on Dimensions.
Article in Journal of Hepatocellular Carcinoma (February 2023)
Article in National Medical Journal of China (September 2022)
Article in Scientific Reports (September 2022)